Alicia Secor

Chief Operating Officer, SYNAGEVA BIOPHARMA CORP.

Companies

ZEVRA THERAPEUTICS, INC.Board member Dec 9, 2025 to now¹
G1 Therapeutics, Inc.Board member Jun 21, 2021 to Sep 18, 2024²
Orchard TherapeuticsBoard member Jan 2, 2020 to Jan 24, 2024³
Zafgen (United States)Chief Commercial Officer Jun 18, 2014 to Apr 4, 2016⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

G1 Therapeutics, Inc.0 shares⁵Sep 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 18, 2024U 10,000 shares of G1 Therapeutics, Inc.⁵
Sep 18, 2024Returned to company 20,000 shares of G1 Therapeutics, Inc.⁵
Jun 13, 2024Granted 10,000 shares of G1 Therapeutics, Inc.⁶
Jun 15, 2023Granted 10,000 shares of G1 Therapeutics, Inc.⁷
Jun 23, 2022Granted 10,000 shares of G1 Therapeutics, Inc.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZEVRA THERAPEUTICS, INC., Board member
2
SEC EDGARG1 Therapeutics, Inc., Board member
3
SEC EDGAROrchard Therapeutics, Board member
4
SEC EDGARZafgen (United States), Chief Commercial Officer
5
SEC EDGARG1 Therapeutics, Inc. shares after the filing of Sep 18, 2024
6
SEC EDGARForm 4 filed Jun 14, 2024
7
SEC EDGARForm 4 filed Jun 16, 2023
8
SEC EDGARForm 4 filed Jun 24, 2022